13F HOLDINGS REPORT
BIOS Capital Management, LP
Quarter ended Q2 2025 · Filed August 12, 2025 · Accession 0001104659-25-076893
Total Value
$72.6M
Positions
9
Other Managers
1
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACTUATE THERAPEUTICS INC | ACTU | 8,509,224 | $52.0M | 71.64% |
| 2 | ACTUATE THERAPEUTICS INC | ACTU | 1,455,855 | $8.9M | 12.26% |
| 3 | OPUS GENETICS INC | IRD | 3,683,429 | $3.5M | 4.77% |
| 4 | LANTERN PHARMA INC | LTRN | 1,075,952 | $3.4M | 4.68% |
| 5 | REIN THERAPEUTICS INC | RNTX | 1,498,751 | $2.1M | 2.89% |
| 6 | COGNITION THERAPEUTICS INC | CGTX | 5,499,905 | $1.7M | 2.35% |
| 7 | IN8BIO INC | INAB | 286,664 | $599,128 | 0.83% |
| 8 | REIN THERAPEUTICS INC | RNTX | 192,000 | $268,800 | 0.37% |
| 9 | COGNITION THERAPEUTICS INC | CGTX | 500,095 | $155,029 | 0.21% |